ECAT: Saba Capital sells shares at $16.58–$16.62
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of common shares over three dates.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of common shares over three dates. The transactions were: 13,647 shares at $16.62 on 10/09/2025, 26,858 shares at $16.59 on 10/10/2025, and 19,408 shares at $16.58 on 10/13/2025. Following these sales, Saba reported 27,618,258 shares beneficially owned indirectly.
Positive
- None.
Negative
- None.
Insights
Insider trimmed position by a very small amount; ownership remains large and indirect. Neutral signal.
The filing reports open‑market sales of **BlackRock ESG Capital Allocation Term Trust (ECAT)** shares by a reporting person over three days: 13,647 shares at
This reduces the reported holder’s stake by about
What it means: a large holder executed modest sales across several days at prices around
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 19,408 | $16.58 | $322K |
| Sale | Common Stock | 26,858 | $16.59 | $446K |
| Sale | Common Stock | 13,647 | $16.62 | $227K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital disclose for ECAT in this Form 4?
What is Saba Capital’s relationship to ECAT?
Were the ECAT transactions direct or indirect holdings?
Were any derivative securities involved in these ECAT transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.